Details of the Drug Formulaction

General Information of Drug Formulation (ID: F11007)

• Formulation Name: Labetalol 300 mg tablet
• Company: Actavis Pharma; American Health Packaging

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Labetalol	(DMK8U72)	Hypertension	BA00-BA04	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Crospovidone	(E00626)	Not Available	Disintegrant
FD&C blue no. 2	(E00446)	2723854	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent